Frazier Life Sciences IX L.P. 13D and 13G filings for Phathom Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-26 4:00 pm Purchase |
2022-09-22 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences IX L.P. | 8,424,772 21.500% |
203,448 (+2.47%) |
Filing |
| 2022-08-11 3:55 pm Purchase |
2022-08-09 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences IX L.P. | 8,221,324 21.000% |
2,377,400 (+40.68%) |
Filing |
| 2020-12-23 1:08 pm Unchanged |
2020-12-21 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences IX L.P. | 5,843,924 18.700% |
0 (Unchanged) |
Filing |
| 2020-06-16 7:37 pm Sale |
2020-06-12 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences IX L.P. | 5,843,924 20.200% |
-1,440,345 (-19.77%) |
Filing |